C A Linker

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi request reprint Autologous stem cell transplantation for acute myeloid leukemia in first remission
    C A Linker
    University of California, San Francisco, USA
    Biol Blood Marrow Transplant 6:50-7. 2000
  2. ncbi request reprint The role of autologous transplantation for acute myeloid leukemia in first and second remission
    Charles Linker
    Department of Medicine, University of California, San Francisco Cancer Center, 400 Parnassus Avenue, Room A 502, San Francisco, CA 94143, USA
    Best Pract Res Clin Haematol 20:77-84. 2007
  3. ncbi request reprint The cancer and leukemia group B transplant committee
    Charles Linker
    University of California at San Francisco, San Francisco, California and Wake Forest, Winston Salem, North Carolina, USA
    Clin Cancer Res 12:3635s-7s. 2006
  4. doi request reprint Auto-SCT for AML in second remission: CALGB study 9620
    C A Linker
    Department of Medicine, University of California, San Francisco, CA 94143, USA
    Bone Marrow Transplant 44:353-9. 2009
  5. ncbi request reprint Recombinant human thrombopoietin augments mobilization of peripheral blood progenitor cells for autologous transplantation
    Charles Linker
    Department of Hematology Oncology, University of California San Francisco, 400 Parnassus Avenue, Room A502, San Francisco, CA 94143, USA
    Biol Blood Marrow Transplant 9:405-13. 2003
  6. ncbi request reprint Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia
    Charles Linker
    Bone Marrow Transplant Program, Medical Center, University of California San Francisco, 400 Parnassus Avenue, Rm A502, San Francisco, CA 94143 0324, USA
    J Clin Oncol 20:2464-71. 2002
  7. ncbi request reprint Autologous stem cell transplantation for advanced acute myeloid leukemia
    C A Linker
    University of California, San Francisco, CA, USA
    Bone Marrow Transplant 29:297-301. 2002
  8. ncbi request reprint Autologous stem cell transplantation for acute myeloid leukemia
    C A Linker
    Division of Hematology Oncology, University of California, San Francisco, USA
    Bone Marrow Transplant 31:731-8. 2003
  9. ncbi request reprint Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remission
    Martin S Tallman
    Northwestern University Medical School, Chicago, Illinois, USA
    Biol Blood Marrow Transplant 12:204-16. 2006
  10. ncbi request reprint Cytoreduction of lymphoid malignancies and mobilization of blood hematopoietic progenitor cells with high doses of cyclophosphamide and etoposide plus filgrastim
    Lloyd Damon
    University of California, San Francisco, San Francisco, California 94143 0324, USA
    Biol Blood Marrow Transplant 12:316-24. 2006

Detail Information

Publications11

  1. ncbi request reprint Autologous stem cell transplantation for acute myeloid leukemia in first remission
    C A Linker
    University of California, San Francisco, USA
    Biol Blood Marrow Transplant 6:50-7. 2000
    ..Preliminary efficacy analysis is very encouraging, with outcomes that appear superior to those of conventional chemotherapy...
  2. ncbi request reprint The role of autologous transplantation for acute myeloid leukemia in first and second remission
    Charles Linker
    Department of Medicine, University of California, San Francisco Cancer Center, 400 Parnassus Avenue, Room A 502, San Francisco, CA 94143, USA
    Best Pract Res Clin Haematol 20:77-84. 2007
    ....
  3. ncbi request reprint The cancer and leukemia group B transplant committee
    Charles Linker
    University of California at San Francisco, San Francisco, California and Wake Forest, Winston Salem, North Carolina, USA
    Clin Cancer Res 12:3635s-7s. 2006
    ..The cooperative group setting allows us to advance the transplant field by showing which approaches are successful outside of single institutions and are therefore feasible on a generalized basis...
  4. doi request reprint Auto-SCT for AML in second remission: CALGB study 9620
    C A Linker
    Department of Medicine, University of California, San Francisco, CA 94143, USA
    Bone Marrow Transplant 44:353-9. 2009
    ..We conclude that this two-step approach to autologous transplantation produces good CD34+ mobilization and that this approach has cured some patients. Results in patients with APL are especially promising...
  5. ncbi request reprint Recombinant human thrombopoietin augments mobilization of peripheral blood progenitor cells for autologous transplantation
    Charles Linker
    Department of Hematology Oncology, University of California San Francisco, 400 Parnassus Avenue, Room A502, San Francisco, CA 94143, USA
    Biol Blood Marrow Transplant 9:405-13. 2003
    ..We conclude that rhTPO can safely enhance mobilization of PBPC, reduce the number of leukapheresis, and allow more patients to meet minimal cell yield requirements to receive high-dose chemotherapy with PBPC transplantation...
  6. ncbi request reprint Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia
    Charles Linker
    Bone Marrow Transplant Program, Medical Center, University of California San Francisco, 400 Parnassus Avenue, Rm A502, San Francisco, CA 94143 0324, USA
    J Clin Oncol 20:2464-71. 2002
    ..To assess the efficacy and toxicity of a new treatment program of intensified and shortened cyclical chemotherapy (protocol 8707) in adults with acute lymphoblastic leukemia (ALL)...
  7. ncbi request reprint Autologous stem cell transplantation for advanced acute myeloid leukemia
    C A Linker
    University of California, San Francisco, CA, USA
    Bone Marrow Transplant 29:297-301. 2002
    ..We conclude that this two-step approach to autologous transplantation produces excellent stem cell yields, allows a high percentage of patients to receive the intended therapy, and provides effective treatment...
  8. ncbi request reprint Autologous stem cell transplantation for acute myeloid leukemia
    C A Linker
    Division of Hematology Oncology, University of California, San Francisco, USA
    Bone Marrow Transplant 31:731-8. 2003
    ..For patients with AML in second remission, ABMT/ASCT offers a substantial salvage rate, and is particularly effective for patients with acute promyelocytic leukemia...
  9. ncbi request reprint Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remission
    Martin S Tallman
    Northwestern University Medical School, Chicago, Illinois, USA
    Biol Blood Marrow Transplant 12:204-16. 2006
    ..Outcomes with standard-dose and high-dose cytarabine were similar. Based on our findings, we recommend that patients with AML in first remission receive consolidation before undergoing autotransplantation...
  10. ncbi request reprint Cytoreduction of lymphoid malignancies and mobilization of blood hematopoietic progenitor cells with high doses of cyclophosphamide and etoposide plus filgrastim
    Lloyd Damon
    University of California, San Francisco, San Francisco, California 94143 0324, USA
    Biol Blood Marrow Transplant 12:316-24. 2006
    ....
  11. ncbi request reprint High CD34+ cell dose promotes faster platelet recovery after autologous stem cell transplantation for acute myeloid leukemia
    Nathan Gunn
    Department of Medicine, Division of Hematology Oncology, University of California San Francisco, 400 Parnassus Avenue, San Francisco, CA 94143, USA
    Biol Blood Marrow Transplant 9:643-8. 2003
    ..0 versus 9.8 units; P =.01). Our findings suggest that CD34+ cell doses >10 x 10(6)/kg CD34+ result in faster engraftment and fewer red blood cell and platelet transfusions...